Abstract:Background Abnormal expression of long non-coding RNAs (lncRNA) play a significant role in the incidence and progression of high-grade serous ovarian cancer (HGSOC), which is a leading cause of mortality among gynecologic malignant tumor patients. In this study, our aim is to identify lncRNA-associated competing endogenous RNA (ceRNA ) axes that could define more reliable prognostic parameters of HGSOC, and to investigate the lncRNAs’ potential mechanism of in lymphocyte infiltration. Methods The RNA-seq and miRNA expression profiles were downloaded from The Cancer Genome Atlas (TCGA) and the Genotype-Tissue Expression (GTEx) database; while for obtaining the differentially expressed lncRNAs (DELs), miRNAs (DEMs), and genes (DEGs), we used edgeR, limma and DESeq2. After validating the RNA, miRNA and gene expressions, using integrated three RNA expression profiles ( GSE18520 , GSE27651 , GSE54388 ) and miRNA profile ( GSE47841 ) from the Gene Expression Omnibus (GEO) database, we performed Gene Ontology (GO) and Kyoto Encyclopedia of Gene and Genome (KEGG) pathway analyses through ClusterProfiler. The prognostic value of these genes was determined with Kaplan–Meier survival analysis and Cox regression analysis. The ceRNA network was constructed using Cytoscape. The correlation between lncRNAs in ceRNA network and immune infiltrating cells was analyzed by using Tumor IMmune Estimation Resource (TIMER), and gene markers of tumor-infiltrating immune cells were identified using Spearman’s correlation after removing the influence of tumor purity. Results A total of 33 DELs (25 upregulated and eight downregulated), 134 DEMs (76 upregulated and 58 downregulated), and 1,612 DEGs (949 upregulated and 663 downregulated) were detected that could be positively correlated with overall survival (OS) of HGSOC. With the 1,612 analyzed genes, we constructed a ceRNA network, which indicated a pre-dominant involvement of the immune-related pathways. Furthermore, our data revealed that LINC00665 influenced the infiltration level of macrophages and dendritic cells (DCs). On the other hand, FTX and LINC00665, which may play their possible roles through the ceRNA axis, demonstrated a potential to inhibit Tregs and prevent T-cell exhaustion. Conclusion We defined several prognostic biomarkers for the incidence and progression of HGSOC and constructed a network for ceRNA axes; among which three were indicated to have a positive correlation with lymphocyte infiltration, namely: FTX-hsa-miR-150-5p-STK11, LINC00665-hsa-miR449b-5p-VAV3 and LINC00665-hsa-miR449b-5p-RRAGD.

Identification of Lncrna-Associated Cerna Network in High-Grade Serous Ovarian Cancer Metastasis

Analysis of Long Non-Coding RNA Expression Profiles Using RNA Sequencing in Ovarian Endometriosis.

Integrated Microrna and Mrna Signatures in Peripheral Blood Lymphocytes of Familial Epithelial Ovarian Cancer.

Identification of a Potential Prognostic Lncrna‐mirna‐mrna Signature in Endometrial Cancer Based on the Competing Endogenous RNA Network

Identification of AP002498.1 and LINC01871 as prognostic biomarkers and therapeutic targets for distant metastasis of colorectal adenocarcinoma

Integrated analysis of lymphocyte infiltration-associated lncRNA for ovarian cancer via TCGA, GTEx and GEO datasets

Construction and Integrated Analysis of a Lncrna-Associated Competing Endogenous RNA Network Reveal Functional Lncrnas in Pancreatic Cancer

Construction of Endometrial Carcinoma ceRNA Network and Screening of Key Genes Based on TCGA Database

Key Nodes of a Microrna Network Associated with the Integrated Mesenchymal Subtype of High-Grade Serous Ovarian Cancer

Integrated Bioinformatical Analysis of Lncrna-Mrna Co-Expression Profiles of Cervical Cancer

Co-expression Network Analysis of the Lncrnas and Mrnas Associated with Cervical Cancer Progression

Systematic Analyses Reveal Long Non-Coding RNA (Ptaf)-Mediated Promotion of EMT and Invasion-Metastasis in Serous Ovarian Cancer

Construction and Investigation of an LINC00284-Associated Regulatory Network in Serous Ovarian Carcinoma.

Identification of lncRNA–miRNA–mRNA regulatory network associated with epithelial ovarian cancer cisplatin‐resistant

Identification of Cerna Network Based on a RNA-seq Shows Prognostic Lncrna Biomarkers in Human Lung Adenocarcinoma

Identifying Prognostic Biomarkers in Endometrial Carcinoma Based on Cerna Network

LncRNAs expression profiling in normal ovary, benign ovarian cyst and malignant epithelial ovarian cancer

Identification of Lncrna Biomarkers in Hepatocellular Carcinoma by Comprehensive Analysis of the Lncrna-Mediated Cerna Network

The Identification and Analysis of mRNA-lncRNA-miRNA Cliques From the Integrative Network of Ovarian Cancer.

Identification of Key lncRNA–mRNA Pairs and Functional lncRNAs in Breast Cancer by Integrative Analysis of TCGA Data

Identification and validation of an m7G-related lncRNAs signature for predicting prognosis, immune response and therapy landscapes in ovarian cancer